Saturday, September 15, 2012

HyProCure® Classified as a Type II EOTTS Device: Improved Design and Function



New Published Research on the EOTTS with HyProCure® Procedure.

The Journal of Foot & Ankle Surgery Article, September 2012
Extra-Osseous Stabilization Devices: A New Classification System. Visit http://www.jfas.org/article/S1067-2516(12)00242-6/abstract for the article abstract.




Key Conclusions:
  • It has been acknowledged that a device that better matches the anatomical shape of the tarsal sinus and follows its natural orientation would allow for better biomechanical functioning.
  • Only Type II devices (HyProCure®) meet the ideal parameters,which has an impact on their improved success rates.
  • This improved design and function may also contribute to the success of Type II (HyProCure®) devices in decreasing the effects of or even eliminating secondary pathologies.

Thursday, September 13, 2012

Evidence for Surgical Treatment of Hyperpronation Using HyProCure® Device

New Published Research on the EOTTS with HyProCure® Procedure.

The Journal of Foot & Ankle Surgery Article, September 2012
Surgical Treatment of Hyperpronation Using an Extra-Osseous TaloTarsal Stabilization Device: Radiographic Outcomes in Adult Patients. Visit http://www.jfas.org/article/S1067-2516(12)00239-6/abstract for the article abstract.




Key Conclusions:
  • EOTTS with HyProCure® was effective in controlling motion in the desired planes without causing overcorrection or blocking in other planes.
  • Stabilization of the TTM with HyProCure® is effective in restoring the normal range of pronation and supination, which is essential for the reduction of strain and force on the soft tissues and osseous structures of the foot and ankle.

Monday, September 10, 2012

German Female Athlete Gets Back in Action, Thanks to HyProCure®

HyProCure®, a sinus tarsi stent made by GraMedica®, a global orthopedic medical device company, is gaining traction worldwide. In an article published in the most recent edition of Orthopädie & Rheuma (Orthopedic & Rheumatology), a German medical journal, Dr. Axel Schroth described the importance of stabilizing the talotarsal mechanism for the treatment of flexible flat feet and the benefits of HyProCure® over other treatment options.

Dr. Axel Schroth is an orthopedic surgeon specializing in foot and ankle surgery. Dr. Schroth practices at the Orthopaedic Specialist Center Weilheim / Garmisch-Partenkirchen / Starnberg (OFZ) in Weilheim, Bavaria, Germany. He is a member of the German Orthopaedic Foot and Ankle Society (DAF) and the German Association for Foot Surgery (GFFC).

Read full article here.

Sunday, September 9, 2012

Find a HyProCure® Trained Physician Near You.


The Graham International Implant Institute is committed to elevating the standard of care in the arena of Extra-Osseous TaloTarsal Stabilization (EOTTS) through education. In addition, we continue to look for and represent other innovative, revolutionary products that help solve foot disorders at their root and don't just ameliorate the symptoms.

Find a specialist near you today! http://hyprocure.com/doctor-locator/

Monday, September 3, 2012

23-year-old HyProCure® Patient


“I have worn orthotics in my shoes since the age of 6 and have experienced continually worsened chronic foot, ankle, knee, hip and back pain. I had never realized that orthotics were simply a “Band-Aid” solution – then I heard about HyProCure®

This has been a life-changing surgery for me. My knee pain has disappeared completely, and my hip is no longer sore and causing me to limp. I feel better every day as my body adjusts to its new alignment – I am SO excited to be free of my chronic pain, and to be walking normally for the first time in my life, at the age of 23.

I am SO THANKFUL for this surgery, and would recommend it to anyone experiencing chronic pain from flat feet!!!”

View more HyProCure® testimonials at www.HyProCure.com.